RBS 3149
Alternative Names: RBS-3149Latest Information Update: 06 May 2022
At a glance
- Originator Riboscience
- Class Antivirals; Nucleosides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Respiratory syncytial virus infections
Most Recent Events
- 22 Apr 2022 Early research in Respiratory syncytial virus infections in USA (Parenteral) (Riboscience pipeline, April 2022)